Context Therapeutics (CNTX) vs TransCode Therapeutics (RNAZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Context Therapeutics (CNTX) has outperformed TransCode Therapeutics (RNAZ) over the past year, losing 72.3% versus a loss of 85.6%. TransCode Therapeutics is the larger company by market cap ($30.3 million vs $28.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTX | RNAZ |
|---|---|---|
| Share price | $0.3108 | $1.79 |
| Market cap | $28.56M | $30.31M |
| 1-day change | -0.58% | +1.70% |
| YTD return | -78.73% | -74.23% |
| 1-year return | -72.34% | -85.60% |
| 5-year return | — | -100.00% |
| EPS (TTM) | $-0.48 | $-52.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.62 | $15.94 |
| 52-week low | $0.297 | $1.52 |
| Distance from 52-week high | -91.41% | -88.77% |
| Average volume | 1.83M | 50.80K |
| Shares outstanding | 91.88M | 16.93M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CNTX has outperformed RNAZ by 13.3 percentage points over the past year.
CNTX vs RNAZ FAQ
Which is bigger, Context Therapeutics or TransCode Therapeutics?
TransCode Therapeutics (RNAZ) is larger, with a market capitalization of $30.31M compared with $28.56M for Context Therapeutics (CNTX).
Which stock has performed better over the past year, CNTX or RNAZ?
CNTX returned -72.34% over the past 12 months, compared with -85.60% for RNAZ (price return, excluding dividends). Past performance does not predict future results.
Are Context Therapeutics and TransCode Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.